MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
VolitionRx Limited Shares 2011-2026 | VNRX
Annual Shares VolitionRx Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96.1 M | 81.9 M | 57.9 M | 53.8 M | 43.4 M | 39.2 M | 31.4 M | 26.4 M | 23 M | 17.7 M | 13.4 M | 10.8 M | 9.36 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 96.1 M | 9.36 M | 38.8 M |
Quarterly Shares VolitionRx Limited
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110 M | 104 M | 101 M | 96.1 M | 92.4 M | 82.9 M | 82.1 M | 81.9 M | 78.3 M | 78.1 M | 63.1 M | 57.9 M | 57.5 M | 53.8 M | 53.8 M | 53.8 M | 53.2 M | 52.9 M | 50.9 M | 48.6 M | 47 M | 43.4 M | 41.2 M | 41.1 M | 39.9 M | 38.9 M | 36.2 M | 35.3 M | 32.8 M | 30 M | 27.3 M | 26.5 M | 26.5 M | 26.4 M | 26.1 M | 26.1 M | 23.5 M | 23.4 M | 19.3 M | 18.8 M | 18 M | 17.9 M | 16.5 M | 14.7 M | 13.5 M | 13.4 M | 12.2 M | 11.7 M | 11.7 M | 11.7 M | 11.7 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 8.65 M | 8.65 M | 8.65 M | 8.65 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 110 M | 8.65 M | 39.2 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Biomerica
BMRA
|
2.3 M | $ 2.13 | -2.74 % | $ 4.89 M |  USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 25.75 | 3.0 % | $ 715 M | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 195.6 | 0.17 % | $ 21.7 B | USA |
 |
DexCom
DXCM
|
390 M | $ 65.94 | -1.51 % | $ 25.7 B | USA |
 |
Brainsway Ltd.
BWAY
|
31.2 M | $ 13.71 | 0.37 % | $ 99.4 M | Israel |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 16.33 | 5.29 % | $ 494 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
189 M | $ 104.91 | - | $ 19.8 B | USA |
 |
Interpace Biosciences
IDXG
|
4.39 M | $ 1.71 | 0.73 % | $ 7.5 M | USA |
 |
Illumina
ILMN
|
159 M | $ 123.79 | -0.43 % | $ 19.7 B | USA |
 |
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 158.0 | 2.86 % | $ 7.83 B | USA |
 |
IQVIA Holdings
IQV
|
172 M | $ 166.96 | 0.52 % | $ 28.7 B | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 75.73 | -0.92 % | $ 5.11 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
IDEXX Laboratories
IDXX
|
80.4 M | $ 578.51 | 0.22 % | $ 46.5 B | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
BioNano Genomics
BNGO
|
1.27 M | $ 1.46 | 26.96 % | $ 1.86 M | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 456.93 | 0.98 % | $ 13.2 B | USA |
 |
Agilent Technologies
A
|
304 M | $ 112.02 | 0.65 % | $ 34.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 100.35 | 0.65 % | $ 8.28 B |  Irlanda |
 |
DarioHealth Corp.
DRIO
|
3.98 M | $ 7.5 | -6.13 % | $ 29.9 M | Israel |
 |
Guardant Health
GH
|
125 M | $ 84.9 | -0.33 % | $ 10.6 B | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.66 | 1.75 % | $ 432 M | USA |
 |
Psychemedics Corporation
PMD
|
5.74 M | - | -1.84 % | $ 15.3 M | USA |
 |
QIAGEN N.V.
QGEN
|
223 M | - | - | $ 10.6 B |  Niderland |
 |
NeoGenomics
NEO
|
128 M | $ 8.1 | 1.76 % | $ 1.04 B | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 17.51 | 1.1 % | $ 392 M | USA |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 239.07 | 2.87 % | $ 25.5 B |  Schweiz |
 |
Natera
NTRA
|
98.4 M | $ 200.09 | 2.46 % | $ 19.7 B | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 17.56 | 2.39 % | $ 936 M | USA |
 |
ENDRA Life Sciences
NDRA
|
537 K | $ 3.48 | 0.87 % | $ 1.87 M | USA |
 |
OPKO Health
OPK
|
694 M | $ 1.15 | 2.68 % | $ 798 M | USA |
 |
Celcuity
CELC
|
39.4 M | $ 106.75 | 0.67 % | $ 4.21 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 264.42 | 0.54 % | $ 22 B | USA |
 |
Personalis
PSNL
|
59.3 M | $ 7.61 | 4.82 % | $ 451 M | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |